Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patientâs breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
äŒæ¥ã³ãŒãINSP
äŒç€ŸåInspire Medical Systems Inc
äžå Žæ¥May 03, 2018
æé«çµå¶è²¬ä»»è
ãCEOãHerbert (Timothy P)
åŸæ¥å¡æ°1246
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«May 03
æ¬ç€Ÿæåšå°5500 Wayzata Blvd Ste 1600
éœåžGOLDEN VALLEY
蚌åžååŒæNASDAQ OMX NASDAQ Basic NYSE
åœUnited States of America
éµäŸ¿çªå·55416-1237
é»è©±çªå·17639575037
ãŠã§ããµã€ãhttps://www.inspiresleep.com/
äŒæ¥ã³ãŒãINSP
äžå Žæ¥May 03, 2018
æé«çµå¶è²¬ä»»è
ãCEOãHerbert (Timothy P)